Excess volume and moderate quality of inpatient care following DRG implementation in Germany

Similar documents
Changes in the hospital care environment impacting on nurses workforce conditions a European perspective Reinhard Busse, Prof. Dr. med.

ABC of DRGs the European Experience

Moving from passive to active provider payment systems: DRG-based financing

Does tariff re-design drive value in health care?

International Innovations to Improve the Quality and Value of Health Care: The German case

England: Europe s healthcare reform laboratory? Peter C. Smith Imperial College Business School and Centre for Health Policy

Taiwan s s Healthcare Industry. Taiwan Institute of Economic Research Dr. Julie C. L. SUN 16 January 2007

Towards more comparable data to assess the performance of health systems: Past, present and future work at OECD

EuroHOPE: Hospital performance

PERFORMANCE OF THE BELGIUM HEALTH SYSTEM IN INTERNATIONAL COMPARISON

Trends in hospital reforms and reflections for China

Implementation of the System of Health Accounts in OECD countries

Prof. Dr. med. Reinhard Busse, MPH

The EU ICT Sector and its R&D Performance. Digital Economy and Society Index Report 2018 The EU ICT sector and its R&D performance

Case-mix Analysis Across Patient Populations and Boundaries: A Refined Classification System

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

Putting Finland in the context

Diagnosis Related Groups in Ukraine

A Primer on Activity-Based Funding

Saint-Luc Transformation: Impacted by Belgian Network Regulation?

Impact of Future Healthcare Reform on the Practice of Occupational Medicine

Quality Based Impacts to Medicare Inpatient Payments

Nursing as Integral Part of Building a Culture of Health. John R. Lumpkin, MD, MPH Senior Vice President Robert Wood Johnson Foundation

The Voice of Foreign Companies. Healthcare Policy Agenda. Bringing the Benefits of Innovative Practices to Denmark

Current Trends in Mental Health Services. Nick Bouras Professor Emeritus

Sir John Oldham National Clinical Lead Quality and Productivity NHS England Jan 2010

Integrated Care Experiences and Outcomes in Germany, the Netherlands and England

What can we learn from European healthcare?

Choice of a Case Mix System for Use in Acute Care Activity-Based Funding Options and Considerations

Conference on Health Payment Reform NH Citizens Health Initiative/NH Dept of Health and Human Services May 11, 2009

Payment innovations in healthcare and how they affect hospitals and physicians

Eliminating Excessive, Unnecessary, and Wasteful Expenditures: Getting to a High Performance U.S. Health System

From the origins of DRGs to their implementation in Europe

Equal Distribution of Health Care Resources: European Model

Euro Health Consumer Index 2009

BETTER IT BETTER HOSPITAL?

Improving Hospital Performance. creating synergy between. payment models

Medical Device Reimbursement in the EU, current environment and trends. Paula Wittels Programme Director

A strategy for building a value-based care program

Can We Lower Low-Value Care? Policy Measures and Lessons in Australia, Canada, England, France, and Germany

Leadership and Governance

EUREKA and Eurostars: Instruments for international R&D cooperation

Casemix Measurement in Irish Hospitals. A Brief Guide

Alliance of Technology Transfer Professionals

Pediatric Population Health

VARIABILITY IN HEALTHCARE TREATMENT COSTS AMONGST NINE EU COUNTRIES RESULTS FROM THE HEALTHBASKET PROJECT

Brian Donovan. Head of Pricing 2 nd July 2015

SAVING LIVES AND CREATING IMPACT. EU investment in poverty-related neglected diseases

The Future of Healthcare Credit Analysis - Seven Emerging Ratios

Assessing cluster organisation management excellence: Indicators and tools

Health Workforce Policies in OECD Countries

Approaches to quality improvement in. study

Descriptive Note. Coordinator: European Centre for Social Welfare Policy and Research Vienna

HEALTH WORKFORCE PLANNING AND MOBILITY IN OECD COUNTRIES. Gaetan Lafortune Senior Economist, OECD Health Division

An action plan to boost research and innovation

Managing Healthcare Payment Opportunity Fundamentals CENTER FOR INDUSTRY TRANSFORMATION

JRM Journal of Rehabilitation Medicine

A European workforce for call centre services. Construction industry recruits abroad

London, Brunei Gallery, October 3 5, Measurement of Health Output experiences from the Norwegian National Accounts

The Role of Analytics in the Development of a Successful Readmissions Program

Pricing and funding for safety and quality: the Australian approach

Are current primary health care funding arrangements getting us where we want to go?

Transitioning Care to Reduce Admissions and Readmissions. Sven T. Berg, MD, MPH Julie Mobayed RN, BSN, MPH

Integrating mental health into primary health care across Europe

Remaking Health Care in America

Spreading knowledge about Erasmus Mundus Programme and Erasmus Mundus National Structures activities among NARIC centers. Summary

Pay-for-Performance. GNYHA Engineering Quality Improvement

THE NATIONAL INVESTMENT IN RESEARCH. Professor Vicki Sara Chair, Australian Research Council

TRENDS IN HEALTH WORKFORCE IN EUROPE. Gaétan Lafortune, OECD Health Division Conference, Brussels, 17 November 2017

3M Health Information Systems. 3M Clinical Risk Groups: Measuring risk, managing care

SOUTH AFRICA EUREKA INFORMATION SESSION 13 JUNE 2013 How to Get involved in EUROSTARS

The EuroDRGproject: DRG systemsanddeterminantsof hospitalcareacrosseurope

Hospital Pharmacists making the difference in medication use

MEASURING R&D TAX INCENTIVES

APPENDIX B: Organizational Profiles of International Digital Government Research Sponsors. New York, with offices in Geneva, Vienna, and Nairobi

A new report helps you understand a changing sector, with forecasts for the coming years. Compare the private and public hospitals sector in Europe

Is Canadian Medicare dying?

HEALTH CARE NON EXPENDITURE STATISTICS

Global Value Chains: Impacts and Implications. Aaron Sydor Office of the Chief Economist Foreign Affairs and International Trade Canada

Replication analysis of the validity and comparability of Patient Safety Indicators (PSI): the impact of AHRQ exclusions

OVERVIEW OF HEALTH WORKFORCE PROJECTION MODELS IN 18 OECD COUNTRIES. Gaetan Lafortune Senior Economist, OECD Health Division

Unmet health care needs statistics

Generosity of R&D Tax Incentives

Medicare Part A SNF Payment System Reform: Introduction to Resident Classification System - I

AGENCY WORK BUSINESS INDICATOR: NOVEMBER 2016 EVOLUTION OF NUMBER OF HOURS WORKED BY AGENCY WORKERS IN EUROPE. Sept 2016.

LESSONS LEARNED IN LENGTH OF STAY (LOS)

Key Performance Indicators What does it mean for Hospital Authority?

Bernd Wächter, ACA English-Taught Programmes in Europe. Results from an ACA study.

Overview on diabetes policy frameworks in the European Union and in other European countries

Employment in Europe 2005: Statistical Annex

MACRA, MIPS, QPP, and APMs.

By Wilm Quentin, David Scheller-Kreinsen, Miriam Blümel, Alexander Geissler, and Reinhard Busse

Doctor visits: Expensive in US - Macedonia a model

Measuring R&D in the Nonprofit Sector: The European Experience

Expert Rev. Pharmacoeconomics Outcomes Res. 2(1), (2002)

Admissions and Readmissions Related to Adverse Events, NMCPHC-EDC-TR

Alpbach Technology Forum, The Efficiency of RTI Investments, 26 August 2011 EU RESEARCH : VALUE FOR MONEY?

INPATIENT HOSPITAL REIMBURSEMENT

THE WORLD BANK EXPERIENCE ON RESEARCH & INNOVATION IN THE WESTERN BALKANS

Volume to Value Based Healthcare Dr. Thilo Koepfer, VP International, 3M Health Information Systems

Transcription:

Excess volume and moderate quality of inpatient care following DRG implementation in Germany Reinhard Busse, Prof. Dr. med. MPH FFPH Dept. Health Care Management, Technische Universität Berlin, Germany (WHO Collaborating Centre for Health Systems Research and Management) & European Observatory on Health Systems and Policies 1

Of course, since its inception in 23, Germany s DRG system (G-DRGs) has been constantly improved and is rightly considered a world leader 2

annual revisions have improved the cost-predictive value of the country-wide weights and make up-coding harder - Early years: Major revisions to increase precision Later years: development has stabilized Year 23 24 25 26 28 21 212 214 DRGs total 664 824 878 954 1137 12 1193 1196 Base-DRGs 411 471 614 578 64 69 595 588 236 454 353 318 293 29 287 4 5 7 8 9 9 9 9 Inpatient DRGs total 664 824 878 952 1132 1195 1189 1191 - valuated 642 86 845 912 189 1154 1149 1148 - unvaluated 22 18 33 4 43 41 4 43 Day care DRGs total 2 5 5 5 5 - valuated 1 1 1 1 2 - unvaluated 1 4 4 4 3 R2 all cases.4556.5577.6388.685.729.7443.754.7671 R2 inlier.6211.722.7796.7884.8166.843.844.8533 Unsplit Severity levels 3

using more classification criteria than in many other countries ENG EST GER 4

while base rates are used to accomodate regional differences Relative cost weight Patient characteristics Gender, Age, Diagnoses, Severity Base rate X = Hospital individual until 29; Uniform state-wide from 21 Treatment options Procedures, Technologies, G-DRG payment Intensity Payment example: Normal birth without cc in Berlin in 21 Relative cost weight.541 X Base rate Berlin 2927.5 = Payment 1584 5

and LOS adjustments and supplementary fees individualize payment to avoid skimping/ creaming and to incentivize innovations Relative cost weight + Supplementary fees X Base rate + LOS adjustment Year For services not (yet) included in DRG cost weights G-DRG payment = 23 24 25 26 28 21 212 214.1229.71.1148.27.1257.63.1265.7.1168.97.1373.76.1465.34.1464.14 Supplementary fees 26 71 83 115 143 15 159 - valuated 1 35 41 64 81 82 95 - unvaluated 25 36 42 51 62 64 64 Range of cost weights: min.-max. (rounded) 6

resulting in costs per case which are moderate in international comparison US$ PPP Bypass 4 35 3 25 2 15 1 5 SLV GER ISR KOR POR SWE AUS CAN FRA Source: Koechlin, F., L. Lorenzoni and P. Schreyer (21), Comparing Price Levels of Hospital Services Across Countries: Results of Pilot Study, OECD Health Working, Papers, No. 53, OECD Publishing. http://dx.doi.org/1.1787/5km91p4f3rzw-en FIN NOR USA

resulting in costs per case which are moderate in international comparison US$ PPP Hip Implantation 2 18 16 14 12 1 8 6 4 2 SLV ISR GER KOR FIN POR FRA SWE CAN Source: Koechlin, F., L. Lorenzoni and P. Schreyer (21), Comparing Price Levels of Hospital Services Across Countries: Results of Pilot Study, OECD Health Working, Papers, No. 53, OECD Publishing. http://dx.doi.org/1.1787/5km91p4f3rzw-en AUS USA

which, next to the DRGs per se, is also attributed to the hospital budgets - Sickness funds negotiate activity based DRG budgets every year with every hospital listed in the regional hospital plans Casemix X Base rate - + Surcharges = Hospital budget Budget over-run adjustment (hospital pays back): - - + Supplementary fees 65 % (standard DRGs), 25 % (drugs, medical, polytrauma and burns DRGs), Negotiations for certain DRGs (those that are difficult to predict) Budget under-run adjustment (hospital receives compensation) : - 2% (standard DRGs) 9

BUT overall hospital expenditure has increased noticeably 1,45 2.9% of GDP +41% 1,4 1,35 +32% Increase in cases 1,3 +27% 1,25 GDP Costs/ hospital case Hospital expenditure 1,2 1,15 1,1 1,5 1 22 23 24 25 26 27 28 29 21 211 212 213 2.6% 1

3 Acute care hospital discharges per 1 25 +12% (+1.7%/year for DRG-reimbursed cases) 2-4% 15-16% -29% 1 5 2 Austria Belgium Denmark France Germany Italy Netherlands Norway Spain Sweden Switzerland United Kingdom EU members before May 24 25 21 11

7 Acute care hospital beds per 1 6-12% 5 4-17% 3 2 2-31% -19% 25 21 Austria Belgium Denmark France Germany Italy Netherlands Norway Spain Sweden Switzerland United Kingdom EU members before May 24

Growth in number of cases (27-212) was very different on regional level Average annual change of case numbers 13

Is differing demand responsible for this? Supply Prices Change of case numbers in hospitals Morbidity change leads to change in number of cases Morbidity Proximity to death: More admissions to hospital in order to safe lives Mortality Change of Population: More citizens more cases Population Remaining impact of age Age (Proxy for other determinants ) Getting neutralized, e.g. changed preferences or lifestyles of population Not measurable, not age-related determinants Capacities 14

Demand-side changes (morbidity, mortality, population size) only partially explain increasing case numbers Relative der numbers Fallzahlen RelativeVeränderung change of case Veränderung Mortalität Change due todurch mortality Veränderung Bevölkerungszahl Change due todurch population Fallzahlveränderung insgesamt Change of case numbers Veränderung Morbidität Change due todurch morbidity Einflüsse zusammen Total demand factors 15% 1% 5% % -5% -1% -15% These are the persons born at the end of WW II 5 1 15 2 25 3 35 4 45 5 55 6 65 7 75 8 85 9 Age groups 15

Regional hot spots ( net, i.e. adjusted for all demand-side factors) Hamburg Average annual change of case numbers Ingolstadt 16

Summary demand side Variation of the population age structure seems to have the biggest effect on the demand side resulting in a slight increase of numbers. Age is after controlling for all other demand factors associated with case numbers but not linearly increasing (maybe due to agerelated treatment options) and distribution of age-effect between supply and demand remains unclear. Regional distribution shows that, after controlling for other demand factors, increasing case numbers are clustered within regions Relatively and absolutely strong growing MDCs have a below average influence on demand. 17

Relative change of case numbers Looking at the supply-side: incentives work changes of cost weights correlate with case numbers Size of effect: +.2% more cases per +1% increase in DRG weight (i.e. +1.9%/ year instead +1.7%) doubling of case increase for DRG weight increase of +8% Relative change of cost weights 18

Relative change of case numbers and hospitals which decrease LOS most increase case numbers most (or vice versa?) Relative change of ALOS 19

Summary - supply side A 1 % change of DRG-weights leads to an attributable.2 % change of case numbers hospitals respond on price changes which is a usual economic reaction A statement on the medical appropriateness of increasing numbers is not possible (yet) Infrastructural overcapacities might have a huge influence on increasing case numbers Effect of other revenue components (e.g. supplementary fees) can t be estimated First evidence on supply behaviour of hospitals in the DRG-era in Germany, more research necessary 2

Implications and considerations for service steering Constant and representative group for calculation of cost weights More diagnosis (instead of procedure) orientation for DRGs Mandatory and interdisciplinary medical second opinion for selected diagnoses More weight on reimbursement components for availability of e.g. emergency capacities Reform of hospital planning and investment financing mechanisms Redefinition of budget overrun regulation More collaboration between ambulatory and hospital sector overcome borders More evaluation and scientific competition better data 21

What about quality? Cost and survival of AMI patients in 1 European hospitals 1.85.9.95 cost 1.5 1.1 C+ C -.1 Q -.5 survival FINLAND GERMANY SWEDEN.5 Q+.1 FRANCE SPAIN Based on Häkkinen et al. 22 Health Policy 214

Staffing makes a big difference (shown here for AMI patients admitted in Berlin 24-27 within/ outside core hours and with/without physician-escorted EMS) + 6% + 4% + 9% Maier et al., Clin Res Cardiol 21 23

1.5 1.1 1.15 Cost and survival of stroke patients in 94 European hospitals.85.9.95 1 cost C+ C -.1 Q -.5 survival FINLAND GERNANY SWEDEN 24.5 Q +.1 FRANCE SPAIN Based on Häkkinen et al. Health Policy 214

no stroke unit (734 hospitals) stroke unit before 27 (26 hospitals) 25 Nimptsch & Mansky, Int J Stroke 213 The wide variation in quality can be explained by the availability of stroke units

Implications and considerations for quality improvement Concentrate services (e.g. AMI is treated in 14 hospitals, with 8 of them having fewer of one patient per week) Better measurement of indication quality More specification of structural quality (e.g. stroke is treated in 13 hospitals, of which only 35% have a stroke unit) Broader publication of quality data Quality agreements with hospitals during budget negotiation or hospital planning Pay-for-performance 26

Linking quality to DRGs our proposals for Germany Patient-based Indication Quality Structural Quality Process Quality Outcome No payment if no indication DRG/ disease-based (all cases Hospital-based (all with same DRG/ diagnosis) cases within hospital) Deduction per DRG and share on case without indication; no payment if minimum quantity for specific treatments is not reached Unverified procedure codes are neglected by grouping algorithm Certain DRGs are not billable if specific structures are not in place (e.g. Stroke Unit) Hospital acquired infections are neglected by grouping algorithm Best practice DRG-weights if costs for better quality are proven to be higher Payment rules for unplanned Surcharge for significant above readmissions average quality Reporting of No payment if quality data is Deductions if quality data is not not available available for numerous cases Quality Budget deduction if structural deviation from hospital plan Base rate deduction if quality data is wrong or incomplete 27

G-DRG-based hospital payment: Conclusion Strengths Weaknesses Transparency and improved documentation No system to reward/penalize hospitals for quality Fair (uniform) reimbursement Minimal (only state-based) adjustment for different input prices Precision of DRG system Increasing complexity with number of DRGs Precision of cost weight calculation Uniform accounting system but no full sample of hospitals Transparent methodology of developing and updating the system Weak instruments to manage hospital volumes 28

www.eurodrg.eu www.mig.tu-berlin.de 8 June 215 DRGs in Europe - towards transparency, efficiency, and quality? 29